Pharmafit Provence
DIARALIA Cpr Plq/40

Boiron

DIARALIA Cpr Plq/40

CIP / EAN code: 3400936096646

Product information from VIDAL.

Read the product information

Product information

Find indications, dosage and precautions in the sections below.

Automatic English translation of the French VIDAL document. Original numerical values and units are retained, including decimal commas.

VIDAL
Medicines
SmPC of 29/01/2021

DIARALIA, tablet


Forms and presentations

Tablet


Composition

ARSENICUM ALBUM 9 CH...................................................................................................................................1 mg

CHINA RUBRA 5 CH.............................................................................................................................................1 mg

PODOPHYLLUM PELTATUM 9 CH..........................................................................................................................1 mg

For one tablet of 300 mg

Excipients with known effect: sucrose, lactose monohydrate.


Excipients:

Sucrose, lactose monohydrate, magnesium stearate.



Indications

Homeopathic medicine traditionally used for the short-term treatment of acute transient diarrhoea in adults and children over 6 years of age.



Dosage and administration

Medicine reserved for adults and children over 6 years of age.

Dosage

1 tablet to be sucked, 4 to 6 times a day for a maximum treatment duration of 3 days.

Stop treatment as soon as the symptoms disappear.

Method of administration

Oral use.



Contraindications

Children under 6 years of age due to the risk of choking associated with the pharmaceutical form.



Warnings and precautions

This medicine must not be used in case of vomiting, high fever, or blood in the stools.

Any significant diarrhoea exposes to the risk of fluid and electrolyte loss requiring appropriate rehydration.

This medicine contains sucrose. Its use is not recommended in patients with fructose intolerance, glucose-galactose malabsorption syndrome or sucrase/isomaltase deficiency.

This medicinal product contains lactose. Its use is not recommended in patients with galactose intolerance, Lapp lactase deficiency or glucose-galactose malabsorption syndrome (rare hereditary disorders).



Fertility, pregnancy and breastfeeding

Given the high dilutions of the strains making up DIARALIA, tablet, this medicine may be taken during pregnancy and breastfeeding.



Adverse effects

Reporting of suspected adverse reactions

Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system: National Agency for the Safety of Medicines and Health Products (ANSM) and the network of Regional Pharmacovigilance Centres - Website:www.signalement-sante.gouv.fr



Pharmacodynamics

Pharmacotherapeutic class: Homeopathic medicine.

The indication for this medicine is based on the traditional homeopathic use of the preparations that make it up.



Shelf life

5 years



Special storage precautions

No special precautions for storage.



Prescription, supply and reimbursement

Marketing authorisation (AMM)
CIP 3400936096646 (Blister/40).
Not reimbursed by Social Security.

Boiron
2 AVENUE DE L'OUEST LYONNAIS
69510 MESSIMY
Tel: 04 78 45 61 00 Tel (toll-free no.): 0 800 10 10 20
https://www.boiron.fr/

Source: VIDAL · Updated on 10/11/2026. This information does not replace advice from a healthcare professional.